Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae

Int J Antimicrob Agents. 2010 Aug;36(2):145-50. doi: 10.1016/j.ijantimicag.2010.03.018. Epub 2010 Jun 1.

Abstract

Vaginal microbicides with activity towards organisms that cause sexually transmitted infections have been proposed as a strategy to reduce transmission. Small-molecule inhibitors of Chlamydia trachomatis serovar D belonging to the class of salicylidene acylhydrazides (INPs) have been shown to work through a mechanism that involves iron restriction. Expanding on this work, ten INPs were tested against a lymphogranuloma venereum strain of C. trachomatis (serovar L2), Neisseria gonorrhoeae, and hydrogen peroxide-producing Lactobacillus crispatus and Lactobacillus jensenii. Seven INPs had minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations of <50 microM towards C. trachomatis L2. Three INPs had a MIC <12.5 microM against N. gonorrhoeae. Inhibition was reversed by iron, holo-transferrin and holo-lactoferrin but not by the iron-poor forms of these compounds. The compounds exhibited no bactericidal activity toward Lactobacillus. The INPs were not cytotoxic to HeLa 229 cells. When INP 0341 was tested in a mouse model of a Chlamydia vaginal infection there was a significant reduction in the number of mice shedding C. trachomatis up to 4 days after infection (P<0.01). In summary, select INPs are promising vaginal microbicide candidates as they inhibit the growth of two common sexually transmitted organisms in vitro, are active in a mouse model against C. trachomatis, are not cytotoxic and do not inhibit organisms that compose the normal vaginal flora.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Intravaginal
  • Animals
  • Anti-Infective Agents / pharmacology*
  • Anti-Infective Agents / therapeutic use
  • Chlamydia Infections / prevention & control*
  • Chlamydia Infections / transmission
  • Chlamydia trachomatis / drug effects*
  • Disease Models, Animal
  • Female
  • Gonorrhea / prevention & control*
  • Gonorrhea / transmission
  • HeLa Cells
  • Humans
  • Hydrazines / pharmacology*
  • Hydrazines / therapeutic use
  • Lactobacillus / drug effects
  • Mice
  • Mice, Inbred C3H
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Vagina / microbiology*

Substances

  • Anti-Infective Agents
  • Hydrazines
  • INP 0341